Cocrystal Pharma, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Cocrystal Pharma, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q3 2024.
  • Cocrystal Pharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 13, 2024 was 10.2M shares, unchanged year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 10.2M 0 0% Nov 13, 2024 10-Q 2024-11-13
Q2 2024 10.2M 0 0% Aug 14, 2024 10-Q 2024-08-14
Q1 2024 10.2M +2.03M +24.9% Mar 28, 2024 10-K 2024-03-28
Q3 2023 10.2M +2.03M +24.9% Nov 13, 2023 10-Q 2023-11-13
Q2 2023 10.2M Aug 14, 2023 10-Q 2023-08-14
Q1 2023 8.14M -89.3M -91.6% Mar 21, 2023 10-K 2023-03-29
Q3 2022 8.14M Nov 14, 2022 10-Q 2022-11-14
Q1 2022 97.5M +26M +36.4% Mar 23, 2022 10-K 2022-03-23
Q4 2021 97.5M Nov 15, 2021 10-Q 2021-11-15
Q2 2021 97.5M +45.3M +86.9% Aug 12, 2021 10-Q 2021-08-16
Q1 2021 71.5M +19.3M +37.1% Mar 15, 2021 10-K 2021-03-17
Q3 2020 68.6M +33.4M +95.1% Nov 13, 2020 10-Q 2020-11-13
Q2 2020 52.1M +20.5M +64.9% Aug 6, 2020 10-Q 2020-08-06
Q1 2020 52.1M +20.5M +64.9% Mar 30, 2020 10-K 2020-03-27
Q3 2019 35.2M +5.23M +17.5% Nov 8, 2019 10-Q 2019-11-12
Q2 2019 31.6M +1.7M +5.67% Aug 9, 2019 10-Q 2019-08-09
Q1 2019 31.6M +7.22M +29.6% Mar 29, 2019 10-K 2019-04-01
Q3 2018 29.9M -698M -95.9% Nov 6, 2018 10-Q 2018-11-09
Q2 2018 29.9M -697M -95.9% Aug 9, 2018 10-Q 2018-08-09
Q1 2018 24.4M -690M -96.6% Mar 16, 2018 10-K 2018-03-21
Q3 2017 728M +14.2M +1.99% Nov 4, 2017 10-Q 2017-11-08
Q2 2017 727M +22.3M +3.16% Aug 4, 2017 10-Q 2017-08-08
Q1 2017 714M +10M +1.42% Mar 24, 2017 10-K 2017-03-31
Q3 2016 714M Nov 7, 2016 10-Q 2016-11-09
Q2 2016 704M +9.88M +1.42% Aug 5, 2016 10-Q 2016-08-09
Q1 2016 704M +30.4M +4.51% Mar 10, 2016 10-K 2016-03-15
Q4 2015 694M Nov 16, 2015 10-Q 2015-11-16
Q2 2015 694M +572M +469% Aug 13, 2015 10-Q 2015-08-14
Q1 2015 674M +553M +459% Mar 23, 2015 10-K 2015-03-31
Q3 2014 122M Nov 14, 2014 10-Q 2014-11-14
Q2 2014 122M +52.3M +75.2% Aug 8, 2014 10-Q 2014-08-14
Q1 2014 121M +57.4M +90.8% Mar 26, 2014 10-K 2014-03-31
Q4 2013 75.7M Nov 15, 2013 10-Q 2013-11-18
Q2 2013 69.6M +9.18M +15.2% Jul 31, 2013 10-Q 2013-08-15
Q1 2013 63.1M +6.66M +11.8% Apr 1, 2013 10-K 2013-04-01
Q3 2012 63.1M -4.39M -6.5% Nov 14, 2012 10-Q 2012-11-14
Q2 2012 60.4M May 21, 2012 10-Q/A 2012-10-02
Q1 2012 56.5M Apr 6, 2012 10-K 2012-04-16
Q4 2011 68.1M Nov 21, 2011 10-Q 2011-11-21
Q3 2011 67.5M Aug 22, 2011 10-Q/A 2011-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.